| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Radiology, Vol 195, 705-709, Copyright © 1995 by Radiological Society of North America
ARTICLES |
HC Steinert, RA Huch Boni, A Buck, R Boni, T Berthold, B Marincek, G Burg and GK von Schulthess
Department of Medical Radiology, University Hospital, Zurich, Switzerland.
PURPOSE: To evaluate whole-body positron emission tomography (PET) with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose (FDG) in the detection of metastasis from melanoma. MATERIALS AND METHODS: Whole-body PET was performed in 33 patients with either known metastatic or newly diagnosed melanoma. Patients with suspected metastases also underwent computed tomography, magnetic resonance imaging, or both. Diagnoses were confirmed with histologic examination or with at least one imaging modality in addition to PET. Blinded interpretations of PET scans were performed. RESULTS: Forty of 53 lesions evaluated proved to be melanoma metastases. Whole-body PET correctly depicted 37 sites of metastases. Three cutaneous metastases (< 3 mm) were missed. PET correctly excluded malignancy in 10 cases where suspicious lesions were found with conventional cross-sectional imaging modalities but later ruled out with fine-needle biopsy. In six patients, PET depicted new metastases. The sensitivity for the detection of malignant lesions was 92%; the specificity for reading the PET images without clinical information was 77% and with clinical information was 100%. CONCLUSIONS: These results suggest that whole-body FDG PET is an effective imaging modality to screen for metastases from malignant melanoma.
This article has been cited by other articles:
|
|
 |
|
  K. Strobel, R. Dummer, D. B. Husarik, M. Perez Lago, T. F. Hany, and H. C. Steinert High-Risk Melanoma: Accuracy of FDG PET/CT with Added CT Morphologic Information for Detection of Metastases Radiology, August 1, 2007; 244(2): 566 - 574. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Huddart, M. J. O'Doherty, A. Padhani, G. J.S. Rustin, G. M. Mead, J. K. Joffe, P. Vasey, S. J. Harland, J. Logue, G. Daugaard, et al. 18Fluorodeoxyglucose Positron Emission Tomography in the Prediction of Relapse in Patients With High-Risk, Clinical Stage I Nonseminomatous Germ Cell Tumors: Preliminary Report of MRC Trial TE22 The NCRI Testis Tumour Clinical Study Group J. Clin. Oncol., July 20, 2007; 25(21): 3090 - 3095. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Maeda, U. Tateishi, S. Suzuki, Y. Arai, E. E. Kim, and K. Sugimura Magnetic Resonance Screening Trial for Hepatic Metastasis in Patients with Locally Controlled Choroidal Melanoma Jpn. J. Clin. Oncol., April 1, 2007; 37(4): 282 - 286. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Aloia, J. E. Gershenwald, R. H. Andtbacka, M. M. Johnson, C. W. Schacherer, C. S. Ng, J. N. Cormier, J. E. Lee, M. I. Ross, and P. F. Mansfield Utility of Computed Tomography and Magnetic Resonance Imaging Staging Before Completion Lymphadenectomy in Patients With Sentinel Lymph Node-Positive Melanoma J. Clin. Oncol., June 20, 2006; 24(18): 2858 - 2865. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Wagner Fluorodeoxyglucose Positron Emission Tomography for Melanoma Staging: Refining the Indications Ann. Surg. Oncol., April 1, 2006; 13(4): 444 - 446. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Fuster, S. Chiang, G. Johnson, L. M. Schuchter, H. Zhuang, and A. Alavi Is 18F-FDG PET More Accurate Than Standard Diagnostic Procedures in the Detection of Suspected Recurrent Melanoma? J. Nucl. Med., August 1, 2004; 45(8): 1323 - 1327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Finkelstein, J. A. Carrasquillo, J. M. Hoffman, B. Galen, P. Choyke, D. E. White, S. A. Rosenberg, and R. M. Sherry A Prospective Analysis of Positron Emission Tomography and Conventional Imaging for Detection of Stage IV Metastatic Melanoma in Patients Undergoing Metastasectomy Ann. Surg. Oncol., August 1, 2004; 11(8): 731 - 738. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Wagner Editorial: A Role for FDG-PET in the Surgical Management of Stage IV Melanoma Ann. Surg. Oncol., August 1, 2004; 11(8): 721 - 722. [Full Text] [PDF]
|
|
|
|
 |
|
 S. W. Fosko, W. Hu, T. F. Cook, and V. J. Lowe Positron Emission Tomography for Basal Cell Carcinoma of the Head and Neck Arch Dermatol, September 1, 2003; 139(9): 1141 - 1146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. V. Dizendorf, B. G. Baumert, G. K. von Schulthess, U. M. Lutolf, and H. C. Steinert Impact of Whole-Body 18F-FDG PET on Staging and Managing Patients for Radiation Therapy J. Nucl. Med., January 1, 2003; 44(1): 24 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H C Steinert and G K von Schulthess Initial clinical experience using a new integrated in-line PET/CT system Br. J. Radiol., November 1, 2002; 75(90009): S36 - 38. [Full Text] [PDF]
|
|
|
|
|
|
S. M. Swetter, L. A. Carroll, D. L. Johnson, and G. M. Segall Positron Emission Tomography Is Superior to Computed Tomography for Metastatic Detection in Melanoma Patients Ann. Surg. Oncol., August 1, 2002; 9(7): 646 - 653. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Belhocine, G. Pierard, M. de Labrassinne, T. Lahaye, and P. Rigo Staging of Regional Nodes in AJCC Stage I and II Melanoma: 18FDG PET Imaging versus Sentinel Node Detection Oncologist, August 1, 2002; 7(4): 271 - 278. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. A. Nabi and J. M. Zubeldia Clinical Applications of 18F-FDG in Oncology J. Nucl. Med. Technol., March 1, 2002; 30(1): 3 - 9. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S F Barrington Whole body applications of positron emission tomography in oncology Imaging, September 1, 2001; 13(3): 185 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.M. Acland, C. Healy, E. Calonje, M. O'Doherty, T. Nunan, C. Page, E. Higgins, and R. Russell-Jones Comparison of Positron Emission Tomography Scanning and Sentinel Node Biopsy in the Detection of Micrometastases of Primary Cutaneous Malignant Melanoma J. Clin. Oncol., May 15, 2001; 19(10): 2674 - 2678. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Gambhir, J. Czernin, J. Schwimmer, D. H. S. Silverman, R. E. Coleman, and M. E. Phelps A Tabulated Summary of the FDG PET Literature J. Nucl. Med., May 1, 2001; 42(90050): 1S - 93. [Full Text] [PDF]
|
|
|
|
|
|
A. Dimitrakopoulou-Strauss, L. G. Strauss, and C. Burger Quantitative PET Studies in Pretreated Melanoma Patients: A Comparison of 6-[18F]Fluoro-L-Dopa with 18F-FDG and 15O-Water Using Compartment and Noncompartment Analysis J. Nucl. Med., February 1, 2001; 42(2): 248 - 256. [Abstract] [Full Text]
|
|
|
|
|
|
J. D. Wagner, D. Schauwecker, D. Davidson, J. J. Coleman III, S. Saxman, G. Hutchins, C. Love, and J. T. Hayes Prospective Study of Fluorodeoxyglucose–Positron Emission Tomography Imaging of Lymph Node Basins in Melanoma Patients Undergoing Sentinel Node Biopsy J. Clin. Oncol., May 1, 1999; 17(5): 1508 - 1508. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |
